Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Oncology Institute (TOI) Shares Outstanding (2020 - 2025)

Oncology Institute's Shares Outstanding history spans 6 years, with the latest figure at $100.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 29.85% year-over-year to $100.6 million; the TTM value through Dec 2025 reached $100.6 million, up 29.85%, while the annual FY2025 figure was $100.6 million, 29.85% up from the prior year.
  • Shares Outstanding reached $98.9 million in Q4 2025 per TOI's latest filing, roughly flat from $99.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $99.3 million in Q3 2025 to a low of $5.8 million in Q3 2021.
  • Average Shares Outstanding over 5 years is $74.7 million, with a median of $75.0 million recorded in 2023.
  • The largest YoY upside for Shares Outstanding was 1158.12% in 2022 against a maximum downside of 0.02% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $73.2 million in 2021, then increased by 0.02% to $73.3 million in 2022, then grew by 3.57% to $75.9 million in 2023, then rose by 2.1% to $77.5 million in 2024, then rose by 29.85% to $100.6 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Shares Outstanding are $100.6 million (Q4 2025), $97.6 million (Q3 2025), and $95.0 million (Q2 2025).